Supernus Pharmaceuticals
SUPN
#4326
Rank
A$3.17 B
Marketcap
$57.45
Share price
0.88%
Change (1 day)
41.01%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total debt

Total debt on the balance sheet as of September 2024 : A$60.07 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's total debt is A$60.07 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Supernus Pharmaceuticals - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$60.95 M-90.67%
2022-12-31A$0.65 B10.96%
2021-12-31A$0.58 B9.31%
2020-12-31A$0.53 B-0.31%
2019-12-31A$0.54 B15.58%
2018-12-31A$0.46 B
2017-12-31N/A-100%
2016-12-31A$5.77 M-40.59%
2015-12-31A$9.72 M-69.65%
2014-12-31A$32.04 M-16.9%
2013-12-31A$38.55 M75%
2012-12-31A$22.03 M-23.38%
2011-12-31A$28.75 M-61.05%
2010-12-31A$73.83 M-11.56%
2009-12-31A$83.49 M-21.46%
2008-12-31A$0.10 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.62 B 948.41%๐Ÿ‡บ๐Ÿ‡ธ USA
A$48.99 B 81,465.54%๐Ÿ‡บ๐Ÿ‡ธ USA
A$80.92 B 134,620.73%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.58 B 39,160.35%๐Ÿ‡บ๐Ÿ‡ธ USA
A$56.29 B 93,604.30%๐Ÿ‡บ๐Ÿ‡ธ USA